pdf
Published
2023-02-24
Issue
Section
Formulary Evaluations
Categories
License
Copyright (c) 2023 Eleanor M. Perfetto, Suz Schrandt, Omar A. Escontrías, Laurie B. Burke
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Patient-Centered Core Impacts Sets (PC-CIS): What They Are and What They Are Not
Eleanor M. Perfetto
University of Maryland, School of Pharmacy
Suz Schrandt
exPPect, Alexandria, VA
Omar A. Escontrías
National Health Council, Washington, DC
Laurie B. Burke
University of Maryland, School of Pharmacy and LORA Group, Normal, IL
DOI: https://doi.org/10.24926/iip.v14i1.5264
Abstract
Letter to the Editor
We are writing regarding the Innovations in Pharmacy commentary entitled, “Evidentiary Standards for Patient-Centered Core Impact Value Claims.”(1) We thank Dr. Langley for commenting on the National Health Council’s work on patient-centered core impact sets (PC-CIS), an initiative spearheaded by the nonprofit organization and its membership with multi-stakeholder representation and input.(2-4) While we have tried to be clear and transparent about the intent of PC-CIS, the commentary made it apparent to us we need to (and will) do more to be explicit about what a PC-CIS is and is not, and its possible downstream uses.
We believe the PC-CIS concept was misrepresented in the commentary and want to provide clarification for readers so they can consider the merits of the initiative for themselves.
